PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26305254-9	2015	Mechanistically, the APs treatment suppressed the ROS/MAPK/NF-kappaB signaling pathway, and consequently, reduced CCL-2, ICAM-1 and VCAM-1 expression.	aps	21-24	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	59-68	
32319542-9	2020	Furthermore, APS treatment significantly decreased TGF-beta1-induced EMT and NF-kappaB pathway activation in vitro.	aps	13-16	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	77-86